Skip to contentI
Immunic, Inc.
I
IMUXImmunic, Inc. IMUX Q1 2019 · Immunic, Inc. · ThalerReleased Apr 10, 2019, after the close
10-Q filed Apr 10, 2019, 10 days after period end · 0001280776-19-000032
Q1 2019 · 10-Q
Revenue—
Net Income-$4.31M-$4.31MN/M vs Q1 2018N/M vs Q4 2018 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
-$5.09-$5.09N/M vs Q1 2018N/M vs Q4 2018 Operating Income-$4,662,000N/M Operating Cash Flow-$5,317,000N/M Free Cash Flowderived-$5,324,000N/M Filing lag
ended Mar 31, 2019 · filed Apr 10, 2019 · 10 d after period end